Question 1

Am I eligible for this trial based on my current health and cancer stage?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Neoadjuvant Cemiplimab in Newly Diagnosed or Recurrent Stage I-II Merkel Cell Carcinoma and Locoregionally Advanced Cutaneous Squamous Cell Carcinoma clinical trial (NCT04975152). Contact the study team or your healthcare provider for specific answers.

Question 2

How does Cemiplimab compare to other treatments I might consider?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Neoadjuvant Cemiplimab in Newly Diagnosed or Recurrent Stage I-II Merkel Cell Carcinoma and Locoregionally Advanced Cutaneous Squamous Cell Carcinoma clinical trial (NCT04975152). Contact the study team or your healthcare provider for specific answers.

Question 3

What are the potential side effects of Cemiplimab?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Neoadjuvant Cemiplimab in Newly Diagnosed or Recurrent Stage I-II Merkel Cell Carcinoma and Locoregionally Advanced Cutaneous Squamous Cell Carcinoma clinical trial (NCT04975152). Contact the study team or your healthcare provider for specific answers.

Question 4

How often will I need to come in for treatment and monitoring?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Neoadjuvant Cemiplimab in Newly Diagnosed or Recurrent Stage I-II Merkel Cell Carcinoma and Locoregionally Advanced Cutaneous Squamous Cell Carcinoma clinical trial (NCT04975152). Contact the study team or your healthcare provider for specific answers.

Question 5

What happens if I experience side effects during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Neoadjuvant Cemiplimab in Newly Diagnosed or Recurrent Stage I-II Merkel Cell Carcinoma and Locoregionally Advanced Cutaneous Squamous Cell Carcinoma clinical trial (NCT04975152). Contact the study team or your healthcare provider for specific answers.

Question 6

How will participating in this trial affect my surgery plans?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Neoadjuvant Cemiplimab in Newly Diagnosed or Recurrent Stage I-II Merkel Cell Carcinoma and Locoregionally Advanced Cutaneous Squamous Cell Carcinoma clinical trial (NCT04975152). Contact the study team or your healthcare provider for specific answers.

What this study is about